{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:08:32Z","timestamp":1790820512205,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["602300"],"award-info":[{"award-number":["602300"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2015F3JHMB"],"award-info":[{"award-number":["2015F3JHMB"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bcp.2021.114452","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T15:50:41Z","timestamp":1612367441000},"page":"114452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine"],"prefix":"10.1016","volume":"185","author":[{"given":"Chiara","family":"Paganini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Gramegna Tota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Maurizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Capulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Bourmaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Teti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Cohen-Solal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Forlino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Superti-Furga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2021.114452_b0005","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0022-3476(97)70250-6","article-title":"Growth in diastrophic dysplasia","volume":"130","author":"Makitie","year":"1997","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.bcp.2021.114452_b0010","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0092-8674(94)90281-X","article-title":"The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping","volume":"78","author":"H\u00e4stbacka","year":"1994","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2021.114452_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/humu.1","article-title":"Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 Novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance","volume":"17","author":"Rossi","year":"2001","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.bcp.2021.114452_b0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0945-053X(98)90088-9","article-title":"Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: Relationship to clinical severity and indications on the role of intracellular sulfate production","volume":"17","author":"Rossi","year":"1998","journal-title":"Matrix Biol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114452_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082710","article-title":"Skeletal dysplasias caused by sulfation defects","volume":"21","author":"Paganini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2021.114452_b0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1432-1033.1997.t01-1-00741.x","article-title":"Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia atelosteogenesis type 2","volume":"248","author":"Rossi","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcp.2021.114452_b0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/pdp.22.4.311.321","article-title":"In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias","volume":"22","author":"Rossi","year":"2003","journal-title":"Pediatr. Pathol. Molec. Med."},{"issue":"6","key":"10.1016\/j.bcp.2021.114452_b0040","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/hmg\/ddi079","article-title":"A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype","volume":"14","author":"Forlino","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2021.114452_b0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/BJ20060566","article-title":"In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation","volume":"398","author":"Pecora","year":"2006","journal-title":"Biochem. J."},{"issue":"19","key":"10.1016\/j.bcp.2021.114452_b0050","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1093\/hmg\/ddv289","article-title":"N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia","volume":"24","author":"Monti","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2021.114452_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jchromb.2012.10.022","article-title":"Methodology for a rapid and simultaneous determination of total cysteine, homocysteine, cysteinylglycine and glutathione in plasma by isocratic RP-HPLC","volume":"911","author":"Ferin","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"6","key":"10.1016\/j.bcp.2021.114452_b0060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/glycob\/cwn028","article-title":"A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin\/dermatan sulfates from biological samples","volume":"18","author":"Deakin","year":"2008","journal-title":"Glycobiology"},{"key":"10.1016\/j.bcp.2021.114452_b0065","article-title":"Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification","author":"Paganini","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bcp.2021.114452_b0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1145\/37402.37422","article-title":"Marching cubes: A high resolution 3D surface construction algorithm","volume":"21","author":"Lorensen","year":"1987","journal-title":"ACM SIGGRAPH Comput. Graph."},{"issue":"7","key":"10.1016\/j.bcp.2021.114452_b0075","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114452_b0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bone.2013.01.036","article-title":"Alteration of proteoglycan sulfation affects bone growth and remodeling","volume":"54","author":"Gualeni","year":"2013","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bcp.2021.114452_b0085","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.semcdb.2011.03.004","article-title":"Sulfate in fetal development","volume":"22","author":"Dawson","year":"2011","journal-title":"Semin. Cell Dev. Biol."},{"issue":"26","key":"10.1016\/j.bcp.2021.114452_b0090","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1016\/j.biomaterials.2013.04.064","article-title":"N-acetyl cysteine as an osteogenesis-enhancing molecule for bone regeneration","volume":"34","author":"Yamada","year":"2013","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.bcp.2021.114452_b0095","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1016\/j.xphs.2017.08.004","article-title":"Polyethylene glycol-poly-lactide-co-glycolide block copolymer-based nanoparticles as a potential tool for off-label use of N-acetylcysteine in the treatment of diastrophic dysplasia","volume":"106","author":"Chiesa","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2021.114452_b0100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.lfs.2016.03.003","article-title":"A minireview on N-acetylcysteine: An old drug with new approaches","volume":"151","author":"Elbini Dhouib","year":"2016","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2021.114452_b0105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2013.09.006","article-title":"Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits","volume":"141","author":"Rushworth","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.bcp.2021.114452_b0110","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","article-title":"The chemistry and biological activities of N-acetylcysteine","volume":"1830","author":"Samuni","year":"2013","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.bcp.2021.114452_b0115","doi-asserted-by":"crossref","first-page":"2835787","DOI":"10.1155\/2018\/2835787","article-title":"Biological activities and potential oral applications of N-acetylcysteine: progress and prospects","volume":"2018","author":"Pei","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"12","key":"10.1016\/j.bcp.2021.114452_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23123305","article-title":"Overview on the effects of N-acetylcysteine in neurodegenerative diseases","volume":"23","author":"Tardiolo","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bcp.2021.114452_b0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/17425255.2017.1251580","article-title":"N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects","volume":"13","author":"Minarini","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bcp.2021.114452_b0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2016.02.083","article-title":"The effect of N-acetylcysteine on the incidence of contrast-induced kidney injury: A systematic review and trial sequential analysis","volume":"209","author":"Wang","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bcp.2021.114452_b0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ebiom.2019.03.081","article-title":"Postnatal N-acetylcysteine administration rescues impaired social behaviors and neurogenesis in Slc13a4 haploinsufficient mice","volume":"43","author":"Zhang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2021.114452_b0140","doi-asserted-by":"crossref","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: a brief overview","author":"Jourdan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"issue":"7607","key":"10.1016\/j.bcp.2021.114452_b0145","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2021.114452_b0150","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1038\/s41598-020-65658-x","article-title":"A computational drug repositioning method applied to rare diseases: Adrenocortical carcinoma","volume":"10","author":"Lotfi Shahreza","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2021.114452_b0155","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.drudis.2017.10.009","article-title":"Computational drug repositioning for rare diseases in the era of precision medicine","volume":"23","author":"Delavan","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2021.114452_b0160","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820904016","article-title":"New perspectives on the treatment of skeletal dysplasia","volume":"11","author":"Marzin","year":"2020","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"15","key":"10.1016\/j.bcp.2021.114452_b0165","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1093\/hmg\/ddx171","article-title":"The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta","volume":"26","author":"Gioia","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.bcp.2021.114452_b0170","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1172\/JCI93094","article-title":"Increased intracellular proteolysis reduces disease severity in an ER stress-associated dwarfism","volume":"127","author":"Mullan","year":"2017","journal-title":"J Clin Invest"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:59:05Z","timestamp":1777377545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":34,"alternative-id":["S0006295221000484"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114452","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114452"}}